| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nature's Sunshine Products, Inc. (NATR) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. NATR is classified in the Food Products industry within the Consumer Staples sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 543.3K | $13.25M | - | |
| CEO | 102.9K | $2.51M | - | |
| CFO | 101.0K | $2.46M | - | |
| Pres | 75.8K | $1.85M | - | |
| VP | 67.6K | $1.65M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Lanoy Jonathan David | SVP, Chief Accounting Officer | Sell | 4,000 | $24.70 | $98,800.00 | -7.9% | - | - | |
| Dec 12, 2025 | Yates Bryant J46 | EVP &President, Europe | Sell | 1,700 | $22.29 | $37,893.00 | -1.7% | +10.8% | - | |
| Nov 18, 2025 | Lanoy Jonathan David | SVP, Chief Accounting Officer | Sell | 5,000 | $20.45 | $102,250.00 | -9.8% | +28.1% | - | |
| Nov 14, 2025 | Brower Nathan G | EVP, General Counsel | Sell | 3,800 | $20.81 | $79,078.00 | -7.5% | +25.2% | - | |
| Nov 12, 2025 | Norman Daniel C48 | EVP &President, Asia | Sell | 8,884 | $20.46 | $181,766.64 | -11.8% | +22.6% | - | |
| Aug 29, 2025 | Yates Bryant J46 | EVP &President, Europe | Sell | 9,672 | $16.74 | $161,919.12 | -4.6% | +22.1% | - | |
| Aug 13, 2025 | Lanoy Jonathan David | SVP, Chief Accounting Officer | Sell | 5,000 | $16.51 | $82,550.00 | -9.1% | +19.3% | - | |
| Aug 13, 2025 | Brower Nathan G | EVP, General Counsel | Sell | 9,996 | $16.54 | $165,333.84 | -17.2% | +19.3% | - | |
| Jun 27, 2025 | Shanghai Fosun Pharmaceutical (group) Co., Ltd. | 10% Owner | Sell | 2,854,607 | $11.46 | $32,713,796.22 | -100% | +12.0% | - | |
| Oct 15, 2024 | Shanghai Fosun Pharmaceutical (group) Co., Ltd. | 10% Owner | Sell | 2,300 | $13.02 | $29,946.00 | -3.5% | +8.0% | +15.0% |